Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

1. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

   Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim +7

   Шарҳ мақолаCAR-T cell therapy researchCritical Reviews in Oncology/Hematology20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.review-article.000011

2. Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy

   Qianqian Huang, Fan Tong, Jiantao Chen +5

   Шарҳ мақолаNanoplatforms for cancer theranosticsAdvanced Science20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000021

3. The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders

   Farag M. A. Altalbawy, Zarrina Babamuradova, Lalji Baldaniya +7

   Шарҳ мақолаImmune Cell Function and InteractionExperimental Cell Research20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000131